Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Study of TL117 +/- Paclitaxel in HNSCC
NCT04843098Phase 2Active, not recruiting
- Sponsor
- Suzhou Junde Biotechnology Co., Ltd.
- Start
- May 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TL117 in head and neck squamous cell carcinoma (HNSCC), sponsored by Suzhou Junde Biotechnology Co., Ltd.. Started May 2021; status: active, not recruiting.
02
Drugs
TL117
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04843098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04843098.